tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GNI Group Advances Non-Opioid Pain Therapy with Phase 1 Trial Completion
Company AnnouncementsGNI Group Advances Non-Opioid Pain Therapy with Phase 1 Trial Completion
5d ago
GNI Group Ltd. Expands Global Presence Through Strategic Equity Offering
PremiumCompany Announcements
GNI Group Ltd. Expands Global Presence Through Strategic Equity Offering
21d ago
GNI Group Appoints New Executive Officer to Drive Global Growth
PremiumCompany Announcements
GNI Group Appoints New Executive Officer to Drive Global Growth
27d ago
GNI Group Reports Q2 FY2025 Financial Results with Increased Revenue but Net Loss
PremiumCompany Announcements
GNI Group Reports Q2 FY2025 Financial Results with Increased Revenue but Net Loss
1M ago
3G6 Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
3G6 Upcoming Earnings Report: What to Expect?
1M ago
GNI Group Increases Stake in Gyre Pharmaceuticals to Boost Corporate Value
PremiumCompany AnnouncementsGNI Group Increases Stake in Gyre Pharmaceuticals to Boost Corporate Value
2M ago
GNI Group’s Cullgen Nears Nasdaq Listing After Shareholder Approval
Premium
Company Announcements
GNI Group’s Cullgen Nears Nasdaq Listing After Shareholder Approval
3M ago
GNI Group’s Gyre Therapeutics Begins Phase 1 Trial for PAH Drug in China
Premium
Company Announcements
GNI Group’s Gyre Therapeutics Begins Phase 1 Trial for PAH Drug in China
4M ago
GNI Group’s Gyre Pharmaceuticals Launches Etorel for Pulmonary Fibrosis
PremiumCompany Announcements
GNI Group’s Gyre Pharmaceuticals Launches Etorel for Pulmonary Fibrosis
4M ago
GNI Group’s Subsidiary Gyre Therapeutics Completes Successful Public Offering
PremiumCompany Announcements
GNI Group’s Subsidiary Gyre Therapeutics Completes Successful Public Offering
4M ago
GNI Group’s Liver Fibrosis Drug Achieves Key Trial Success in China
PremiumCompany Announcements
GNI Group’s Liver Fibrosis Drug Achieves Key Trial Success in China
4M ago
Gyre Therapeutics Launches $20 Million Public Stock Offering
PremiumCompany Announcements
Gyre Therapeutics Launches $20 Million Public Stock Offering
4M ago
GNI Group Reports Decline in Q1 FY2025 Financial Results
PremiumCompany AnnouncementsGNI Group Reports Decline in Q1 FY2025 Financial Results
4M ago
GNI Group Confirms NDA Timeline for Hydronidone
Premium
Company Announcements
GNI Group Confirms NDA Timeline for Hydronidone
5M ago
GNI Group Issues Stock Options Tied to Drug Approval Milestone
Premium
Company Announcements
GNI Group Issues Stock Options Tied to Drug Approval Milestone
5M ago
GNI Group Projects Record Sales and Profits Amid U.S.-China Tariff Concerns
PremiumCompany Announcements
GNI Group Projects Record Sales and Profits Amid U.S.-China Tariff Concerns
6M ago
GNI Group Amends FY2024 Financial Results Following Tax Review
PremiumCompany Announcements
GNI Group Amends FY2024 Financial Results Following Tax Review
7M ago
GNI Group Reports FY2024 Financial Decline, Projects Growth in FY2025
PremiumCompany Announcements
GNI Group Reports FY2024 Financial Decline, Projects Growth in FY2025
7M ago
GNI Group Reports Decline in Q2 FY2024 Results
PremiumCompany Announcements
GNI Group Reports Decline in Q2 FY2024 Results
1y ago
GNI Group Earns Spot in Prestigious JPX-Nikkei Index
PremiumCompany AnnouncementsGNI Group Earns Spot in Prestigious JPX-Nikkei Index
1y ago
GNI Group Announces New Drug Approval in China
Premium
Company Announcements
GNI Group Announces New Drug Approval in China
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >